252 related articles for article (PubMed ID: 28635518)
1. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.
Lewis DJ; Byekova YA; Emge DA; Duvic M
J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518
[TBL] [Abstract][Full Text] [Related]
2. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
Chiam LY; Chan YC
Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
[TBL] [Abstract][Full Text] [Related]
4. [Imiquimod in treatment of palpebral mycosis fungoides].
Soler-Machín J; Gilaberte-Calzada Y; Vera-Alvarez J; Coscojuela-Santaliestra C; Martínez-Morales J; Osán-Tello M
Arch Soc Esp Oftalmol; 2006 Apr; 81(4):221-3. PubMed ID: 16688647
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod in mycosis fungoides.
Martínez-González MC; Verea-Hernando MM; Yebra-Pimentel MT; Del Pozo J; Mazaira M; Fonseca E
Eur J Dermatol; 2008; 18(2):148-52. PubMed ID: 18424373
[TBL] [Abstract][Full Text] [Related]
6. Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease.
Sawada M; Kato J; Yamashita T; Yoneta A; Hida T; Horimoto K; Sato S; Uhara H
J Dermatol; 2018 Feb; 45(2):216-219. PubMed ID: 29115681
[TBL] [Abstract][Full Text] [Related]
7. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mycosis fungoides with imiquimod 5% cream.
Ariffin N; Khorshid M
Clin Exp Dermatol; 2006 Nov; 31(6):822-3. PubMed ID: 17040269
[No Abstract] [Full Text] [Related]
9. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides.
Dummer R; Urosevic M; Kempf W; Kazakov D; Burg G
Dermatology; 2003; 207(1):116-8. PubMed ID: 12835571
[TBL] [Abstract][Full Text] [Related]
10. Unilesional mycosis fungoides successfully treated with imiquimod.
Ardigò M; Cota C; Berardesca E
Eur J Dermatol; 2006; 16(4):446. PubMed ID: 16935811
[No Abstract] [Full Text] [Related]
11. Skin directed therapy for mycosis fungoides: a review.
Berthelot C; Rivera A; Duvic M
J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of imiquimod in solitary plaques of mycosis fungoides.
Onsun N; Ufacik H; Kural Y; Topçu E; Somay A
Int J Tissue React; 2005; 27(4):167-72. PubMed ID: 16440581
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
Chong A; Loo WJ; Banney L; Grant JW; Norris PG
J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
[No Abstract] [Full Text] [Related]
14. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.
Cohen PR; Schulze KE; Tschen JA; Hetherington GW; Nelson BR
South Med J; 2006 Apr; 99(4):396-402. PubMed ID: 16634252
[TBL] [Abstract][Full Text] [Related]
15. Long-term control of mycosis fungoides of the hands with topical bexarotene.
Lain T; Talpur R; Duvic M
Int J Dermatol; 2003 Mar; 42(3):238-41. PubMed ID: 12653924
[TBL] [Abstract][Full Text] [Related]
16. Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
Gniadecki R; Paron E
Skin Therapy Lett; 2023 Mar; 28(2):1-5. PubMed ID: 37054720
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
18. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Heisig M; Maj J; Szepietowski JC; Reich A
Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
[TBL] [Abstract][Full Text] [Related]
19. Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational study.
Geller S; Myskowski PL
Cutis; 2020 May; 105(5):E27-E32. PubMed ID: 32603400
[TBL] [Abstract][Full Text] [Related]
20. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
